Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician’s Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma

CARTITUDE-4: ClinicalTrials.gov ID NCT04181827.

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 16-1-2026, 3:36